+ All Categories
Home > Documents > Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry –...

Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry –...

Date post: 26-Mar-2015
Category:
Upload: david-bradley
View: 236 times
Download: 5 times
Share this document with a friend
Popular Tags:
60
Dr. Dr. Ahmed El Missiry Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS Consultant Psychiatrist – Kent & Medway NHS Researcher, Neuropsychopharmacology Department Researcher, Neuropsychopharmacology Department Zurich Institute of Technology, Switzerland Zurich Institute of Technology, Switzerland Regional Representative – Royal College of Psychiatrists Regional Representative – Royal College of Psychiatrists (Addiction – KSS) (Addiction – KSS)
Transcript
Page 1: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Dr.Dr. Ahmed El MissiryAhmed El MissiryDPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law

A Professor of Psychiatry – ASUIP – WHO A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHSConsultant Psychiatrist – Kent & Medway NHS

Researcher, Neuropsychopharmacology DepartmentResearcher, Neuropsychopharmacology DepartmentZurich Institute of Technology, SwitzerlandZurich Institute of Technology, Switzerland

Regional Representative – Royal College of Psychiatrists Regional Representative – Royal College of Psychiatrists (Addiction – KSS) (Addiction – KSS)

Page 2: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

DisclosureDisclosure

In the past three years I received In the past three years I received

Honorariums from ApexPharma, Astra Zeneca, Honorariums from ApexPharma, Astra Zeneca,

BMS, Delta, Janssen Cilag, Lily, Lundbeck, BMS, Delta, Janssen Cilag, Lily, Lundbeck,

Pfizer, WyethPfizer, Wyeth

Research grants from ApexPharmaResearch grants from ApexPharma

Advisory ApexPharma, Janssen Cilag, Pharmed Advisory ApexPharma, Janssen Cilag, Pharmed

International International

Page 3: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

The aches of the psycheThe aches of the psyche ……I do not like my state of mind I do not like my state of mind

I'm bitter, querulous, unkind.I'm bitter, querulous, unkind.I am always anxious and tense I am always anxious and tense

my thoughts make no sense my thoughts make no sense I dread the dawn's recurrent light; I dread the dawn's recurrent light;

I hate to go to bed at night.I hate to go to bed at night.I find no peace in paint or typeI find no peace in paint or type My world is but a lot of tripe. My world is but a lot of tripe. I'm disillusioned, empty-breastedI'm disillusioned, empty-breasted

ForFor what I think, I'd be arrested.what I think, I'd be arrested.I am not sick, I am not wellI am not sick, I am not well

My quondam dreams are shot to hell.My quondam dreams are shot to hell.My soul is crushed, my spirit sore; My soul is crushed, my spirit sore;

I do not like me any more.I do not like me any more.I want to stop this pain I want to stop this pain …… before I turn insane before I turn insane

Adapted poems

Page 4: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Not knowing where he was, his wife Not knowing where he was, his wife inserted her hands under his clothing inserted her hands under his clothing and said:and said:

““My brother, no fever in your My brother, no fever in your chest and limbs, chest and limbs, butbut sadness of sadness of

the heart…the heart…””

Ebbs Papyrus

Page 5: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Greek MythologyGreek Mythology

THE ALGEATHE ALGEA were the were the spirits of pain spirits of pain and suffering of both and suffering of both bodybody and and mind mind and are related to and are related to OizysOizys, the , the goddess goddess of miseryof misery and and sadnesssadness, and , and PenthosPenthos the god of the god of mourning and lamentationmourning and lamentation. .

Mens Sana en Corpora Sana Decimus Iuvenalis

Page 6: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Why Pain, psychological distress Why Pain, psychological distress (Anxiety and Depression)(Anxiety and Depression)??

Anxiety, Depression and Pain Symptoms Anxiety, Depression and Pain Symptoms are highly prevalent conditionsare highly prevalent conditions– Lifetime prevalence of Pain = 24-37%Lifetime prevalence of Pain = 24-37%11

– Lifetime prevalence of Depression = 5-10%Lifetime prevalence of Depression = 5-10%22

– Lifetime prevalence of Anxiety= 20%Lifetime prevalence of Anxiety= 20%22

Anxiety, Depression and Pain complicate Anxiety, Depression and Pain complicate each other, affect outcomes, cause more each other, affect outcomes, cause more morbidity and disability and increase costs. morbidity and disability and increase costs.

Regier DA, Myers JK, Kramer M, et al. The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry.1984;41:934-941. Kessler, R.C., S. Zhao, D.G. Blazer, and M. Swartz, Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord, 1997. 45(1-2): p. 19-30.

Page 7: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Lifetime comorbidity of Lifetime comorbidity of mood and anxiety disordersmood and anxiety disorders

1 Kessler et al, Arch Gen Psychiatry 1995; 2 DSM-IV-TR™ 2000; 3 Brawman-Mintzer et al, Am J Psychiatry 1993;4 Rasmussen et al, J Clin Psychiatry 1992 ; 5Dunner, Depression and Anxiety 2001

DEPRESSION

48% of patients with PTSD1 Up to 65% of patients with Panic Disorder2

67% of patients with Obsessive-Compulsive Disorder4

42% of patients with Generalised Anxiety Disorder3

Up to 70% of patients with Social Anxiety Disorder5

Panic Disorder

GAD

Social Anxiety Disorder

Post-Traumatic Stress Disorder

OCD

“Comorbidity is the rule, not the exception”

Pain

Pain comorbidity= Av 65%

Page 8: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Strength of association (D/R – Predictive)– Can Pain be distressing? What is the prevalence of Anxiety &

depression in painful disorders? – Do depression & anxiety hurt? What is the prevalence of pain

symptoms in Anxiety & depression?

Does the presence of pain affect recognition and

treatment of anxiety / depression?

What is the common neurobiological basis of

pain/anxiety/ depression?

What are the treatments available?

Page 9: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Can pain be distressing ?!!Can pain be distressing ?!!The prevalence of depression in pain disordersThe prevalence of depression in pain disorders [1] [1]

– In general population pain = In general population pain = 18% 18% (4.7%-22%)(4.7%-22%)– In Primary Care clinics = In Primary Care clinics = 27% 27% (5.9%-46%)(5.9%-46%)– In pain clinics = In pain clinics = 52% 52% (1.5%-100%)(1.5%-100%)– In orthopedic clinics = In orthopedic clinics = 56% 56% (21%-89%)(21%-89%)– In dental/facial pain clinics = In dental/facial pain clinics = 85% 85% (35%-100%)(35%-100%)– In gynecology pelvic pain clinics = In gynecology pelvic pain clinics = 13% 13% (12%-17%)(12%-17%)

Prevalence of anxiety disorders in patients with chronic painPrevalence of anxiety disorders in patients with chronic pain– In general population= In general population= 35 % 35 % [2][2]

– back pain clinic = back pain clinic = 20% - 57% 20% - 57% [3,4][3,4]

1- Matthew et al Arch Intern Med. ;163:2433-2445, 20032- Manchikanti et al Pain Physician, Volume 5, Number 2, pp 149-15, 2002 3- Sommer 18th European Congress of Psychiatry. February 27, March 2, 20104- Moya et al Aten Primaria. 2000 Sep 15;26(4):239-44.

Page 10: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

The likelihood of anxiety and depression The likelihood of anxiety and depression increase with the number of painful increase with the number of painful

symptomssymptoms

Kroenke K, Spitzer RL, Williams JB, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med.1994;3:774-779.

One thousand adult patients

PainNAnxietyDepressionAny Symptom

0-12152 (1)5 (2)16 (7)

2-322517 (7)27 (12)50 (22)

4-519125 (13)44 (23)67 (35)

6-823068 (30)100 (44)140 (61)

9+13068 (48)84 (80)113 (81)

Page 11: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Increasing pain predicts increased Increasing pain predicts increased Anxiety & DepressionAnxiety & Depression

0

2

4

6

8

10

12

NPAD-d inlowestquartile

NPAD-d inmiddle

quartiles

NPAD-d inhighestquartile

Depression

Anxiety

<0.001

<0.001

Blozik et al BMC Musculoskelet Disord. 2009 Jan 26;10:13.

N=448

Requited from Primary care

Page 12: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.
Page 13: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Does Depression Hurt?!Does Depression Hurt?!The prevalence of pain in depressed ranged from The prevalence of pain in depressed ranged from 15% 15% toto 100% 100% ( (mean prevalence, 65%mean prevalence, 65%). ).

SourceNo. of PatientsStudy SettingPatients With Pain, %

Bair et al573Primary care69

Delaplaine et al29Psychiatric inpatients51

Diamond432Neurology clinic85

Hollifield et al29Outpatient clinic59

Lindsay and Wyckoff196Private practice59

Mathew et al51Research institution77 Headache37 chest pain

Merskey and Spear85Psychiatric patients56

Pelz et al22Psychiatric patients41

Singhl150Depressed outpatients65

Vaeroy and Merskey28General practice43

von Knorring40Psychiatric inpatients60

von Knorring et al161Psychiatric inpatients57

Ward et al16Respondents to newspaper advertisement

100

Watts 100Psychiatric patients15

Page 14: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Chronic Pain in DepressionChronic Pain in Depression

18 980 subjects representative of the general populations of the United Kingdom, Germany, Italy, Portugal, and Spain.

Ohayon & Schatzberg Arch Gen Psychiatry. 2003;60:39-47

Does Depression Hurt?!Does Depression Hurt?!

Pain was 4 times more likely in subjects with major depressive disorder (OR 4.0; 95% CI, 3.5-4.7)

Page 15: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Does Depression Hurt?!Does Depression Hurt?!Results from the FINDER study

Demyttenaere et al (2010) Journal of Affective Disorders 125 53–60

FINDER was a 6-month prospective, observational study of 3468 outpatients with depression initiating antidepressant treatment.

•56.3% experienced mod/severe pain

•53.6% had mod/severe pain-related interference with functioning.

Page 16: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Graph adapted from Ohayon MM, Schatzberg AF. Arch Gen Psychiatry 2003;60: 39–47.

43% of depressed patients experienced chronic painful symptoms1

Pat

ient

s (%

)

Normal mood (n=18,232)

Participants with at least 1 depressivesymptom (n=3140)Depression – 5 DSM-IV criteria met (n=748)

0

10

20

30

40

50

Backache GI disease Joint/articular

Headache Limb ache 1 Chronicpainful

symptom

*††

* †*

*††

††

††

††

More Depressive Symptoms … More Depressive Symptoms … more painmore pain

Page 17: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Are Pain symptoms a marker for depression?

61 60

4339 39 39 37

0

10

20

30

40

50

60

70

sleepdisturbance

fatigue multiple complaints

(3+)

back pain shortness ofbreath

amplifiedcomplaints

vaguecomplaintsP

osi

tive

Pre

dic

tive

Val

ue

for

Dep

ress

ion

Gerber et al J Gen Intern Med. 1992 Mar-Apr;7(2):170-3

1,042 consecutive outpatients screened for depression

Page 18: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Does Anxiety Hurt?!Does Anxiety Hurt?!

0

10

20

30

40

50

60

Chronic pain (all) Neuropathic pain only

Condition

% o

f sub

ject

s

GAD population (n=13,386) Controls (n=89,971)

Brandenburg et al. Poster presented at The 25th Annual Conference of the Anxiety Disorders Association of America (ADAA) , March 2005, Seattle, WA, USA

***

***

Page 19: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Are Pain symptoms a marker for Anxiety?

n=1000

Kroenke K et al. Arch Fam Med 1994;3:774–779

Pre

va

len

ce

in

an

xie

ty d

iso

rde

rs (

%)

Chest pain Abdominal Headache Fatigue

40

30

20

10

0

33%31%

28% 26%

pain

Page 20: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

77%

52%

38%

23%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

Psychological Initial Somatic FacultativeSomatic

Persistent Somatic

Rec

og

nis

ed b

y C

lin

icia

n (

%) Rates of Recognition of Depression and Anxiety

by Style of Clinical Presentation

Kirmayer LJ et al. Am J Psychiatry 1993; 150: 734-741

Initial presented with 1 psychological

symptom

Initial presented with only 1 somatic

presented with only somatic symptoms

Persistent presented with only somatic & did not believe any

psychological cause

Does Pain affect the recognition of Anxiety & Depressive disorders? More than 50% of depressed or anxious

patients presenting with pain are not recognized

Page 21: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

The Central effect

Stahl, 2008

Why we can not see the depression and anxiety in Why we can not see the depression and anxiety in pain?pain?

Page 22: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

The Central effect

Stahl, 2008

Why we can not see the pain in depression?Why we can not see the pain in depression?

Page 23: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Why we can not see the pain?Why we can not see the pain?Diagnostic Criterion Bias

*Symptoms of GAD and SAD.DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.

Symptom OverlapSymptom OverlapAnxiety*

Depressed mood

Loss of interest or pleasure

Appetite disturbance

Worthlessness

Suicidal ideation

Low self-esteem

AgitationIrritabilityFatigue

Difficulty concentrating

Sleep disturbanceMuscle tensionGI complaints

Pain

Anxiety

Worry

Dry mouth

Palpitations

Sweating

Trembling

Blushing

Stuttering

Depression

Page 24: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

The Spectrum of Symptoms

Emotional SymptomPhysical SymptomsSadness & TearfulnessBody Aches and Pains

Loss of InterestHeadaches

Anxiety / IrritabilityTiredness and Fatigue

HopelessnessSexual dysfunction

Concentration DifficultiesGI Changes

Negative cognitions & GuiltVasomotor changes

Suicidal Ideations

Sleep Disturbances

Appetite \wt changes

Psychomotor problemsAdapted from DSM-IV APA 1994

Why we can not see the depression?Why we can not see the depression?2- Diagnostic Criterion Bias

Page 25: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Affective Spectrum DisordersAffective Spectrum Disordersassociated with painassociated with pain

Mood disorders

Major depressive disorderMajor depressive disorder

Dysthymic disorderDysthymic disorder

Premenstrual dysphoric disorderPremenstrual dysphoric disorder

Bipolar disorder (especially bipolar depression or mixed)Bipolar disorder (especially bipolar depression or mixed)Anxiety / neurotic disorders Anxiety / neurotic disorders

Generalized anxiety disorder Generalized anxiety disorder Panic disorderPanic disorderPosttraumatic stress disorderPosttraumatic stress disorderSomatization / somatoform pain disorders Somatization / somatoform pain disorders

Painful Functional somatic disordersPainful Functional somatic disordersFibromyalgiaFibromyalgiaIrritable bowel syndromeIrritable bowel syndromeMigraineMigraine

Mood disorders

Major depressive disorderMajor depressive disorder

Dysthymic disorderDysthymic disorder

Premenstrual dysphoric disorderPremenstrual dysphoric disorder

Bipolar disorder (especially bipolar depression or mixed)Bipolar disorder (especially bipolar depression or mixed)Anxiety / neurotic disorders Anxiety / neurotic disorders

Generalized anxiety disorder Generalized anxiety disorder Panic disorderPanic disorderPosttraumatic stress disorderPosttraumatic stress disorderSomatization / somatoform pain disorders Somatization / somatoform pain disorders

Painful Functional somatic disordersPainful Functional somatic disordersFibromyalgiaFibromyalgiaIrritable bowel syndromeIrritable bowel syndromeMigraineMigraine

2- Diagnostic Criterion Bias

Page 26: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Stahl, 2008

Page 27: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Somatization Somatization VsVs Psycholization Psycholization::Cheung (1987) described 3 explanatory models for illness;

psychological,

somatic, or mixed

In depression:

• 45-95% Report Somatic symptoms only

•50% Report unexplained symptoms

•11% Denies depression

Why we can not see the depression?Why we can not see the depression?3- Presentation Bias

Page 28: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Depression and anxiety are Often Missed when The Presentation is

Physical

77

22

0102030405060708090

PsychosocialComplains

Somatic Complains

% o

f C

orr

ec

t D

iag

no

sis

of

MD

D/A

D

Adapted from Kirmayer et al AJP1993

N=685

Page 29: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

The effect of poor recognition on The effect of poor recognition on the patient’s treatmentthe patient’s treatment

Mistreatment Mistreatment

Under treatmentUnder treatment

Decreased treatment efficacy Decreased treatment efficacy

PolypharmacyPolypharmacy– Increase risk of side effects /drug interactions Increase risk of side effects /drug interactions – Increase risk of substance misuseIncrease risk of substance misuse

Page 30: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

The effect of poor recognition on The effect of poor recognition on the treatment outcomesthe treatment outcomes

Increase depression Increase depression Increase PainIncrease PainIncrease functional disability Increase functional disability Decrease quality of LifeDecrease quality of LifeIncreased Relapse Rates Increased Relapse Rates Decreased Remission RatesDecreased Remission RatesIncrease health care utilizationIncrease health care utilizationIncrease suicide ratesIncrease suicide rates

Page 31: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Pain is an independent risk factor Pain is an independent risk factor for suicide for suicide [8][8]

Chronic pain associated with increased risk of Chronic pain associated with increased risk of suicidesuicide [1, 2, 3][1, 2, 3] Rates of suicidal ideation & attemptsRates of suicidal ideation & attempts [4, 5][4, 5] Over 30% of chronic pain patients reported suicidal Over 30% of chronic pain patients reported suicidal ideationideation [6][6]

37% of patients receiving opioid therapy reported 37% of patients receiving opioid therapy reported suicidal thoughtssuicidal thoughts & & 20% an attempt20% an attempt [7][7]..Mental pain in is associated with Mental pain in is associated with risk of risk of suicidesuicide [9][9]..

[1] Fishbain et al Clin J Pain. 1991;7:29–36[2] Penttinen et al Am J Public Health. 1995;85:1452–1453. [3] Tang et al Psychol Med. 2006;36:575–586[4] Breslau et al Neurology. 1992;42:392–395.[5] Hinkley et al 1994;9:175–185.[6] Edwards et al Pain. 2006;126:272–279.[7] Saffier et al. K Journal of Substance Abuse Treatment. 2007;33:303–311[8] Ilgen et al Gen Hosp Psychiatry. 2008; 30(6): 521–527. [9] Van Heeringen et al Psychiatry Res. 2010 Feb 28;181(2):141-4.

Page 32: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

““For several years I have been aware of my For several years I have been aware of my own mortalityown mortality, , for some strange reason it for some strange reason it had been on my mind…had been on my mind…Since I have had Since I have had this deteriorating back problem which this deteriorating back problem which causes constant pain and …… a barrier of causes constant pain and …… a barrier of intimacy …intimacy … . I had two spinal interventions . I had two spinal interventions to cure the pain, I had great to cure the pain, I had great disappointment when the first failed, and disappointment when the first failed, and was devastated when the second failed, was devastated when the second failed, ….….I was told nothingI was told nothing… … I have had one I have had one hope and now it is gone …. this feels like hope and now it is gone …. this feels like the sword of Damocles ….the sword of Damocles …. How long it will How long it will be another day, month, several months? be another day, month, several months? Before I…..”Before I…..”

Jan 2008

Page 33: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

The biology of PainThe biology of Pain

Sensory channels:Sensory channels:– Sensory discriminative Sensory discriminative

component component – Motivational affective componentMotivational affective component

Pain ModulationPain Modulation– Spinal ModulationSpinal Modulation (Gate Theory) (Gate Theory)

Melzack and Wall 1965Melzack and Wall 1965

– Descending inhibitionsDescending inhibitionsOpioid system Opioid system 5HT system 5HT system NE system NE system OthersOthers

– Descending facilitationDescending facilitation

Page 34: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Sensory- Discriminatory

pathway

Motivational Affective pathway

Stahl, 2008

Ascending pathways

Page 35: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Descending Inhibitory System

Opiate

(endorphins)

Serotonin

Norepenephrine

Sub P (NK1,2,3)

VIP (VIPR)

Somatostatin

Calcitonin

GABA

Glutamate

Glycine

NMDA

NO

CCK

Sympathetic

Stahl, 2008

Page 36: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Descending Tracts

Page 37: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

PAIN:

Depletion of monoamines

Increase CRF

IL2 – TNF –IL6

DEPRESSION & ANXIETY:

Endogenous OpiatesEndogenous Opiates

NE - NE - 5HT 5HT

CCK

Sub-P

Possible Explanation: Descending Pathways

Page 38: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Distress and pain disorders share the same anatomical sites

Process information from sensory to emotional

(mood & pain)

executive functions & perceived control

over pain

Rational cognitive functions & pain

processing

memory of emotional reactions

Associative and episodic

memories

Reward increases in negative

affects

Page 39: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Induction of Negative Mood Disrupts EmotionInduction of Negative Mood Disrupts EmotionRegulation Neurocircuitry and Enhances PainRegulation Neurocircuitry and Enhances Pain

UnpleasantnessUnpleasantness

Berna C et al. Biol Psychiatry 2010;67:1083-1090

Negative or neutral moods were induced in healthy volunteers who underwent heat pain whilst in an fMRI scanner .

Areas that showed increased activity during pain in the depressed mood state - left insula, thalamus, hippocampus, IFG, dlPFC, OFC, and the sACC. The thalamus and the insular cortex

are part of the afferent nociceptive network .

dlPFC, dorsolateral prefrontal cortex; IFG, inferior frontal gyrus; OFC, orbitofrontal cortex sACC – subgenual anteria cingulate cortex

Pain was rated more unpleasant after the sad mood induction. Depressed mood was associated with increases in negative pain-related cognitions (catastrophizing)

Page 40: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Pain

Proposed cognitive modelsProposed cognitive models

Berna C et al. Biol Psychiatry 2010;67:1083-1090

increased negative mood → increased catastrophizing → increased pain unpleasantness

induced Negative

mood

Pain related cognitions

Increased catastrophizing

(rumination)

Mechanisitic hypothesis: Dysfunction of emotion regulation

Increased cognitive load

Change in neural processing in

prefrontal areas

Increased activity in the

left IFG, dlPFC and OFC

Increased Pain Unpleasantness

More activity in IFG and amygdalae

Strong effect

Less activity in IFG and amygdalae

No effectexplains 58%

variability

explains 34%

variability

dlPFC, dorsolateral prefrontal cortex; IFG, inferior frontal gyrus; OFC, orbitofrontal cortex

Page 41: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

How we can help?

Depressed patients seen in

primary care

Increase Awareness Increase Awareness Better identification Better identification Proper & early treatment for Neuropathic Pain Proper & early treatment for Neuropathic Pain Proper & early treatment for Depression/anxiety Proper & early treatment for Depression/anxiety

Page 42: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Treatment for Neuropathic PainTreatment for Neuropathic PainTreatment / control of cause Treatment / control of cause Alternative treatments Alternative treatments (TENS, Acupuncture)(TENS, Acupuncture)Pharmacotherapy: Pharmacotherapy: – NSAID / Pain KillersNSAID / Pain Killers– SNRIs / TCA SNRIs / TCA – Anti-epileptics Anti-epileptics – Alpha 2 Delta agonists Alpha 2 Delta agonists – Opiate Based preparation !!Opiate Based preparation !!

TMSTMSEpidural blocksEpidural blocks Implantable drug pumpsImplantable drug pumpsNeurostimulationNeurostimulationsurgical interventionssurgical interventionsPsychological: Psychological: CBT for Pain CBT for Pain

Page 43: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Risk of iatrogenic addiction in patients treated with opioids

A systematic review 41 A systematic review 41 studies with conflicting studies with conflicting findings findings Risk can be Risk can be relatively high relatively high (<10%)(<10%) or low or low (<0.1%).(<0.1%). [1][1]

A systematic review noted the A systematic review noted the prevalence of prevalence of [2][2]

– Lifetime SUD 36% to 56%Lifetime SUD 36% to 56%– Current SUD 43%Current SUD 43%– Aberrant medication-taking Aberrant medication-taking

behaviours 5% to 24%behaviours 5% to 24%

[1] Wasan et al. 2006 [2] Martell et al 2007

Risk factors for opioid abuse in patients with chronic pain are [3]: •young age, •male gender,•past alcohol or cocaine abuse, •previous drug conviction, •mental health disorders,•pain in multiple regions,•pain after MVA

[3] Højsted & Sjøgren

Page 44: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Opioid treatment; Opioid treatment; may need a revisitmay need a revisit A large population-based study found that opioid

usage was significantly associated with:more severe pain,poorer self-rated health, lower quality of life, less physical activity, lower employment, higher levels of health careutilization, and more subjects living aloneimpaired neuropsychological performance reaction times, psychomotor speed, and working memory

Højsted & Sjøgren Curr Opin Anaesthesiol. 2007 Oct;20(5):451-5.

Page 45: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

(3)Sustainedabsence ofsymptoms

(3)Sustainedabsence ofsymptoms

(4)Psychosocial and

occupationalfunctioning

restored

(4)Psychosocial and

occupationalfunctioning

restored

Road To RecoveryRoad To Recovery

(1)Response

To treatmen

t

(1)Response

To treatmen

t

(2)Remission of

symptoms

(2)Remission of

symptoms

Aim at Recovery

20-30% 20-30% partial partial

response response (Residual (Residual symptom).symptom).

Quality of Recovery

Symptomatic recovery

Syndromal recovery

Functional recovery.

Treatment of anxiety and depression

Page 46: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Residual Symptoms Predicts Higher Relapse Rates

0

20

40

60

80

100

120

1 2 4 6 8 10 12

Months of Follow-up

Pro

bab

ilit

y o

f R

em

ain

ing

Well (

%

)

Remission (n=41)

Residual Symptoms(n=19)

Rush AJ, et al Psychiatry Ann. 1995; 25: 704

Page 47: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Greco T et al. J Gen Intern Med 2004; 19: 813-818

Depressive symptoms

Positive well being

Non painfulSomatic symptoms

Painful Somatic symptoms

Painful Somatic symptoms may be less responsive to treatment relative to other symptoms

The challenge in treatment

Page 48: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Depressive symptoms

Painful symptoms are associated with worse depression outcome

the ARTIST TrialDepression outcome at 6 month for n=573 Treated in primary care

0.11

0.25

0.72

0.24

0.65 0.67

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

Severe pain Moderate pain Mild pain

Remission

Partial response

DeVeaugh-Geiss ey al Pain Medicine 2010; 11: 732–741

458) 80% (have pain190) 33% (mild pain

165) 29% (moderate pain103) 18% (severe pain

Around 60% adequate treatment was given

Page 49: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Proper identification & early treatment for Proper identification & early treatment for DepressionDepression Pharmacotherapy: Pharmacotherapy: – SNRIs / TCA SNRIs / TCA – Mood stabilizers (CBZ)Mood stabilizers (CBZ)– Alpha 2 Delta agonists Alpha 2 Delta agonists (pregabalin / Gabalin)(pregabalin / Gabalin)– BZDBZD– Pipe Lines: Pipe Lines: NMDA AntagonistsNMDA Antagonists

Somatic Treatment: Somatic Treatment: TMSTMS

Psychosocial: Psychosocial: CBT for Depression, social inclusion & re-habitation CBT for Depression, social inclusion & re-habitation

How to achieve recovery?How to achieve recovery?

Page 50: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Pooled data from Thase et al & Nemerrof et al

What Antidepressant to Use?What Antidepressant to Use?

Page 51: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

What Antidepressant to Use in What Antidepressant to Use in painful depression?painful depression?

Page 52: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

What SNRI to use in Painful Anxiety & What SNRI to use in Painful Anxiety & Depression?Depression?

Duloxetine & Venlafaxine are both effective….Duloxetine & Venlafaxine are both effective….Duloxetine & Venlafaxine are both effective….Duloxetine & Venlafaxine are both effective….

Perahia D et al. Comparing Duloxetine and Venlafaxine in the Treatment of Major Depressive Disorder Using a Global Benefit-Risk Approach. New Clinical Drug Evaluation Unit (NCDEU) Florida 2005

No significant difference at 6 or 12 weeks

-16

-14

-12

-10

-8

-6

-4

-2

0

0 1 2 3 4 6 8 10 12

Leas

t Squ

ares

Mea

n C

hang

e

Duloxetine (n=318)

Venlafaxine XL (n=330)

Weeks

Duloxetine 60mg OD Duloxetine 60-120mg

Ven 75mg OD Ven 150mg OD Ven 150-225mg

Imp

rove

me

nt

Page 53: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

What Antiepileptic to use?What Antiepileptic to use?

Anticonvulsant mechanisms of action

NNTDrug

Decrease in sodium channel activity

Increase in CNS GABA activity

Modulation of

Ca++Channels

Reduction of

excitatory amino acid

activity

Carbamazepine+3.3 (2–9.4)

Gabapentin+++ (?)3.7 (2.4–8.3)

Lamotrigine++Topiramate+++3.0 (2.3–4.5)

Pregabalin++3.3 (2.3–5.9)

Vinik J Clin Endocrinol Metab. 2005 Aug;90(8):4936-45.

Page 54: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Pregabalin

Sibilia Quilici et al BMC Neurology 2009

Page 55: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

PregabalinPregabalin

-20

-18

-16

-14

-12

-10

-8

-6

-4

-2

0

0 1 2 3 4 5 6 7 8 9

Weeks

Me

an

ch

an

ge

fro

m b

as

elin

e

Placebo (n=127)

Venlafaxine XR 75-225 mg/day (n=122)

Pregabalin 300-600 mg/day (n=121)

Telephone assessment on Day 4. Mean baseline HAM-A ~27.5. Change over time based on MMRM analysis. Endpoint: 8 weeks (LOCF, ANCOVA)Herman et al. CINP 2008

EP//

***

***

*

D4

***†

***†

***†

***†

*P<0.05, **P<0.01, ***P0.001 vs. placebo

†P<0.05 vs. venlafaxine

HAM-A score 20 HAM-D score <15

Page 56: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Treatment

Page 57: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Psychological Uses

BehaviouralIncrease exercise/activity levels; overcome fear–avoidance

Cognitive-behavioural

Reduce depression and anxiety associated with pain; develop effective coping strategies; reduce problematic cognitive styles.

InterpersonalAddress role transitions due to pain; relationship difficulties/conflicts

Adjunctive techniques

 

BiofeedbackMuscle relaxation; control of physiological parameters contributing to pain (e.g., headache)

Guided imageryRelaxation; distraction from pain

HypnosisRelaxation; pain severity reduction; distraction

Progressive muscle relaxation

Muscle relaxation; distraction from pain

What other interventions to use?What other interventions to use?

Page 58: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Despite the frequent coexistence of depression , anxiety and

pain the magnitude and implications of that relationship are

still unclear.

Neglecting the treatment of fatigue, low energy , and painful

physical symptoms in depressed patients can lead to

unsatisfactory outcomes, characterized by a failure of

depressed patients to return to normal social and occupational

functioning.

Conclusion:Conclusion:

Keller MB et al 1992 , Judd LL et all 1998, Angst J 1992and Kupfer DJ 1991; Sheline YI et al 1996; Blier P et al. 2001

Page 59: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.
Page 60: Dr. Ahmed El Missiry DPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law A Professor of Psychiatry – ASUIP – WHO Consultant Psychiatrist – Kent & Medway NHS.

Dr.Dr. Ahmed El MissiryAhmed El MissiryDPP Msc (neuro-psych) MD MRCPsych MISAM, LLB LawDPP Msc (neuro-psych) MD MRCPsych MISAM, LLB Law

A A Professor of Psychiatry – ASUIP – WHOProfessor of Psychiatry – ASUIP – WHO

Consultant Psychiatrist – Kent & Medway NHSConsultant Psychiatrist – Kent & Medway NHSResearcher, Neuropsychopharmacology DepartmentResearcher, Neuropsychopharmacology Department

Zurich Institute of Technology, SwitzerlandZurich Institute of Technology, Switzerland Royal College of Psychiatrists Regional Representative KSS – Royal College of Psychiatrists Regional Representative KSS –

AddictionAddiction

Office: Pagoda CMHC Hermitage Lane, Barming Maidstone. Kent ME16 9PDTel: 01622-724200 Mobile: 07876284356 Email: [email protected]


Recommended